The Floodgates are Open: Why Waiting for SBIR Reauthorization is Now a Fiduciary Risk
Show Me the Money – Why Investors Undervalue SBIR Grants
Grant Writing in the Era of AI Workshop at the Non-Dilutive Funding Summit
How to Build a Granting Strategy Workshop at the Non-Dilutive Funding Summit
FreeMind Elite Dionysus Digital Health Presentation at the Non-Dilutive Funding Summit
FreeMind Elite Secretome Therapeutics Presentation at the Non-Dilutive Funding Summit
Breakthrough T1D Presentation at the Non-Dilutive Funding Summit
CIRM Presentation at the Non-Dilutive Funding Summit
CPRIT Presentation at the Non-Dilutive Funding Summit
BARDA Presentation at the Non-Dilutive Funding Summit
ARPA-H Presentation at the Non-Dilutive Funding Summit
House and Senate appropriators endorse NIH budget increase
Recent Posts
Sachs Associates BEF, Basel, Switzerland, October 7-8, 2026September 27, 2026 - 6:51 am
Sachs Associates EHIS, Basel, October 6, 2026September 27, 2026 - 6:48 am
BioFuture, October 27-28, 2026, NYCAugust 2, 2026 - 6:59 am
RESI Boston, September 22-23, 2026, Boston, USAJuly 30, 2026 - 8:42 am
LSX USA Congress, September 23-24, 2026, Boston, USAJuly 30, 2026 - 8:37 am